about bpl

Bio Products Laboratory Ltd.


PRESS RELEASE - 6 June 2016: Bio Products Laboratory launches Coagadex® ▼ (human coagulation factor X) in the UK Treatment for rare bleeding disorder ‘hereditary factor X deficiency’ and is made available in the UK

ELSTREE, UK Bio Products Laboratory, Limited (BPL) today, announced that Coagadex is now available for patients in the UK. Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency. Coagadex is the ...

Date added: Monday 6th June 2016
Latest updated: Wednesday 8th February 2017

Patient information leaflets